Embla Medical hf.
OSSFF
$4.15
$0.071.72%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.82% | 47.20% | -4.15% | 57.36% | 26.40% |
| Total Depreciation and Amortization | 8.07% | -6.67% | 108.49% | 13.44% | 11.89% |
| Total Amortization of Deferred Charges | -- | -- | -76.06% | -- | -- |
| Total Other Non-Cash Items | 71.80% | 119.22% | 158.70% | -102.97% | 104.02% |
| Change in Net Operating Assets | -140.48% | 8.70% | -62.92% | 268.14% | -73.29% |
| Cash from Operations | -22.06% | 242.03% | 14.07% | 53.76% | 14.10% |
| Capital Expenditure | 6.09% | 67.88% | -277.58% | 9.03% | 25.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 60.72% | 95.66% | 223.05% | -230.41% | -28.25% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3,304.39% | -36,153.85% | 108.46% | -45.28% | -59.57% |
| Cash from Investing | 44.93% | 86.48% | 123.36% | 0.66% | 17.94% |
| Total Debt Issued | -- | -90.75% | -1,412.63% | -- | -- |
| Total Debt Repaid | -358.32% | -10.37% | 51.55% | -73.85% | -27.79% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -1,171.01% | -- | -- |
| Cash from Financing | 3.36% | -98.90% | -146.70% | -73.85% | -44.06% |
| Foreign Exchange rate Adjustments | 1,912.71% | 267.10% | -422.77% | 389.20% | 89.04% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,729.17% | 19.17% | 115.94% | 536.87% | 95.06% |